FindTrial
Sign In

Bilirubin in newborn babies of India

Construction Of Transcutaneous Bilirubin Nomogram And To Study The Natural History Of Jaundice In Predominantly Breast Fed Term And Near Term Indian Neonates

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/09/015671
Enrollment
3000
Registered
2018-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Director General Armed Forces Medical Services
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All inborn neonates more than 34 weeks

Exclusion criteria

Exclusion criteria: Neonates with major congenital malformation, admission in NICU, positive direct coomb test (will be done in case of Rh negative mother) and on phototherapy before enrolment will be excluded.

Design outcomes

Primary

MeasureTime frame
Transcutaneous bilirubin during initial admission after birthTimepoint: 12 hourly intervals—

Secondary

MeasureTime frame
Transcutaneous bilirubin on follow upTimepoint: every week till one month of age—

Countries

India

Contacts

Public ContactSubhash Chandra Shaw

Armed Forces Medical College

drscshaw@rediffmail.com7044249430

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026